Company intelligence / Profile preview

LifeMeter

Ownership: Private
Development stage: Other

Overview

LifeMeter is a non-invasive, reflection spectroscopy-based device that measures carotenoid levels in the skin to reflect circulating levels in the body. It has been validated by over 30 peer-reviewed publications involving more than 2,000 subjects of varying demographics. The device provides rapid feedback on carotenoid status following dietary or supplement interventions and is used by healthcare professionals to support visual and overall health management.

Therapeutic areas: OphthalmologyMetabolic DisordersOther
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

No major pharmaceutical or biotech partnerships disclosed.

Beyond the preview

Go deeper on LifeMeter.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LifeMeter.

Explore the full profile